• About
    • Overview
    • Leadership Team
    • Board of Directors
    • Advisors
    • Partnership Opportunities
    • Contact Us
  • Science
    • Addressing Underlying Imbalances
    • Benefits of Our Approach
    • Our Lead Drug, RNS60, Has Promising Results
  • Pipeline
    • Overview
    • RNS60
    • Ischemic Stroke
    • Amyotrophic Lateral Sclerosis (ALS)
    • Discovery Programs
    • Clinical Trials
    • Patient Access
  • News
    • Press Releases
    • Publications & Presentations
  • Careers
    • Culture
    • Open Positions
Connect with us
info@revalesio.com
Connect with us
info@revalesio.com
© Revalesio Corporation. All rights reserved.
1202 East D St
Tacoma, WA 98421, USA
  • Privacy Policy